Logo

Senores Pharmaceuticals Ltd. Share Price

Pharmaceuticals & Drugs

Senores Pharmaceuticals Ltd. (INR)532.5-2   (-0.4%)

Exchange ScripsBSE544319NSESENORESISININE0RB801010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Senores Pharmaceuticals Ltd. Performance

Market performance

Open price531
High542
Volumes123108
Prev Close532.5
Low530.1
Closing date2025-06-18

Historical performance

1 Year High665.00
3 Year High665.00
5 Year High665.00
1 Year Low435.25
3 Year Low435.25
5 Year Low435.25

Senores Pharmaceuticals Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
NaN
Face Value
Face Value (₹)
P/E Ratio
P/E Ratio
Dividend Yield
Dividend Yield
N/A

Senores Pharmaceuticals Ltd. Investment Returns

1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Senores Pharmaceuticals Ltd. Technicals

IndicatorsValueSignal
5-DMA545.49Bearish
10-DMA540.53Bearish
20-DMA526.56Bullish
50-DMA523.02Bullish
100-DMA540.28Bearish
200-DMA

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024
Promoters161616
Foreign Investors333
Domestic Investors131313
Public Investors376374950243691
Government---------

Senores Pharmaceuticals Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Other Income28375
Operating Profit44416424
Interest94216
Depreciation100187
Profit Before Tax24912411
Consolidated Net Profit3158410
Adjusted EPS1091

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Share Capital3059887
Total Reserves1738357278
Minority Interest274------
Total Non-Current Liabilities1277337122
Total Liabilities60691311587
Capital Work in Progress178813
Total Assets60691311587

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Cash Flow from Operating Activities-199-11-104
Cash Flow from Investing Activities-547-483-244
Cash Flow from Financing Activitie870463365
Net Cash Inflow / Outflow125-3116
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 51.64.
  • 3Y Stock Price CAGR of the stock is None.
  • The stock has a beta of 1.6.
  • In the last financial year, the company had an EBITDA of ₹444 Million.
  • The company generated revenue of ₹2145 Million in the previous financial year.

Senores Pharmaceuticals Ltd.

532.5-2   (-0.4%)

Investment Amount: ₹ 1000000
Current Value: ₹ 955928.6
No. of Shares: 1795.2
Performance:-4.4%
P/L: ₹-44071.4

Top Gainers

SymbolChange%
EMIL158.37(18%)
SILLYMONKS18(14%)
OPTIEMUS684.6(11%)
AAKASH9.7(11%)
PFOCUS130.98(10%)

Top Losers

SymbolChange%
ORIENTCEM253.7(-16%)
KBCGLOBAL0.55(-11%)
SHAH4.45(-10%)
MOBIKWIK244.85(-9%)
HAVISHA2.29(-9%)
SGL16.62(-9%)
IKS1703.4(-8%)
STLTECH104.55(-7%)

Similar stocks

Ind-Swift Laboratories Ltd.

45.1

103.35

May 18 - June 18

Onesource Specialty Pharma Ltd.

37.5

2195

May 18 - June 18

Concord Biotech Ltd.

34

2008.9

May 18 - June 18

Pfizer Ltd.

31.3

5792.5

May 18 - June 18

Shilpa Medicare Ltd.

29.7

917.9

May 18 - June 18

Wockhardt Ltd.

29.2

1718.5

May 18 - June 18

Strides Pharma Science Ltd.

29.1

853.8

May 18 - June 18

Venus Remedies Ltd.

26.6

433.95

May 18 - June 18

Announcing Stock of the Month!

Stock of the Month
Stock of the Month